Harmony Biosciences stockHRMY
Harmony Biosciences trades at $32.47, 25.3% below its 52-week high (Sep 3, 2026). The price is below its 50- and 200-day averages, a downtrend. −13.2% year to date, +3.6% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Mar 2, 2027.
Ratings, candles, signals and the screener for HRMY — after you log in
Open the terminalFrequently asked questions about Harmony Biosciences
What is the Harmony Biosciences stock price?
At the close on Nov 5, 2026: $32.47 (−5.65% on the day). 52-week high: $43.49 on Sep 3, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Harmony Biosciences report earnings?
The next quarterly report is on Mar 2, 2027. Last quarter, earnings per share changed −7% year over year, revenue +12%.
Does Harmony Biosciences pay dividends?
No, Harmony Biosciences does not pay dividends.
Where does Harmony Biosciences trade and how to buy it?
Ticker HRMY, exchange Nasdaq, listed since 2020. You can buy it through a broker with access to US exchanges.
Should I buy Harmony Biosciences now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for HRMY are in the terminal after you log in.